Crinetics Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Crinetics Pharmaceuticals, Inc.‘s stocks are currently a part of 69 hedge funds’ portfolios, which represents 29.94% of the total amount of its stocks outstanding. This makes up a total of 15.56M shares of Crinetics Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -71.64% or -39.32M shares fewer. As for the holding position changes, 56.52% (39) of current hedge fund investors increased the number of shares held, 17.39% (12) of current holders sold a part of the shares held, and 7.25% (5) closed the holdings completely. 9 hedge funds are new holders of Crinetics Pharmaceuticals, Inc. stock in Q1 2023, it is 13.04% of total holders.
Hedge funds holding Crinetics Pharmaceuticals (Q3 2018 – Q1 2023)
| Q3 2018 | 49 |
|---|---|
| Q4 2018 | 50 |
| Q1 2019 | 62 |
| Q2 2019 | 61 |
| Q3 2019 | 61 |
| Q4 2019 | 58 |
| Q1 2020 | 56 |
| Q2 2020 | 79 |
| Q3 2020 | 70 |
| Q4 2020 | 84 |
| Q1 2021 | 78 |
| Q2 2021 | 82 |
| Q3 2021 | 92 |
| Q4 2021 | 118 |
| Q1 2022 | 114 |
| Q2 2022 | 111 |
| Q3 2022 | 117 |
| Q4 2022 | 121 |
| Q1 2023 | 69 |
Hedge funds changes in Crinetics Pharmaceuticals positions (Q3 2018 – Q1 2023)
| Q3 2018 | 49 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q4 2018 | 10 | 17 | 11 | 9 | 3 |
| Q1 2019 | 16 | 25 | 9 | 4 | 8 |
| Q2 2019 | 9 | 30 | 8 | 8 | 6 |
| Q3 2019 | 5 | 21 | 17 | 5 | 13 |
| Q4 2019 | 9 | 24 | 11 | 7 | 7 |
| Q1 2020 | 5 | 16 | 21 | 7 | 7 |
| Q2 2020 | 27 | 41 | 8 | 4 | -1 |
| Q3 2020 | 4 | 22 | 24 | 13 | 7 |
| Q4 2020 | 20 | 32 | 15 | 6 | 11 |
| Q1 2021 | 5 | 27 | 25 | 11 | 10 |
| Q2 2021 | 13 | 46 | 13 | 9 | 1 |
| Q3 2021 | 16 | 34 | 20 | 5 | 17 |
| Q4 2021 | 32 | 58 | 19 | 6 | 3 |
| Q1 2022 | 13 | 43 | 38 | 17 | 3 |
| Q2 2022 | 16 | 46 | 30 | 15 | 4 |
| Q3 2022 | 19 | 46 | 27 | 14 | 11 |
| Q4 2022 | 13 | 46 | 35 | 10 | 17 |
| Q1 2023 | 9 | 39 | 12 | 5 | 4 |
Hedge funds changes in Crinetics Pharmaceuticals stock options (Q3 2018 – Q1 2023)
| Q3 2018 | 0 | 0 |
|---|---|---|
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 0 |
| Q4 2021 | 2,000 | 0 |
| Q1 2022 | 2,000 | 6,000 |
| Q2 2022 | 2,572,000 | 5,000 |
| Q3 2022 | 2,506,000 | 0 |
| Q4 2022 | 43,090 | 20,130 |
| Q1 2023 | 109,000 | 0 |